author-photo

Sophie Dimicoli

University of Texas MD Anderson Cancer Center

10

Papers

236

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
A Phase II Add-on Study of Vorinostat (VOR) in Higher Risk Myelodysplastic Syndrome with Failure of Hypomethylating Agents (HMA): The GFM Azavor Study

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (63)
Toll-like receptor alterations in myelodysplastic syndrome

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (96)
Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes

2013 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (44)
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome†

2012 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (24)
Phase II Study of the Histone Deacetylase Inhibitor Panabinostat (LBH589) in Patients with Low or Intermediate-1 Risk Myelodysplastic syndrome

2011 Blood
Show All
- Source
- Cite
- Save
Citations (7)